Infographic: Adalimumab Approvals in the United States and European Union

Competition for the $16 billion market for Humira is heating up with new approvals for adalimumab biosimilars in the United States and European Union.

Competition for the $16 billion market for Humira is heating up with new approvals for adalimumab biosimilars in the United States and European Union.

infographic detailing humira biosimilars approved in the US and EU
Related Videos
Here are the top 5 biosimilar articles for the week of May 1, 2023.
Christine Baeder
Here are the top 5 biosimilar articles for the week of February 13th, 2023.
Michael Kleinrock
Ian Henshaw
Ian Henshaw
John Gabrielson
Ryan Haumschild, PharmD
Paul Reider
Julie M. Reed
Related Content
© 2023 MJH Life Sciences

All rights reserved.